Unexpected Serious Risk
An unexpected serious risk is the risk of a serious adverse experience that is not listed in the labeling of a health product. These usually require rapid reporting to the study sponsor and the Food and Drug Administration.
An unexpected serious risk is the risk of a serious adverse experience that is not listed in the labeling of a health product. These usually require rapid reporting to the study sponsor and the Food and Drug Administration.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
